Haoxi Health Technology Limited
HAO
$0.98
-$0.03-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -32.39% | -10.23% | 15.04% | 37.70% | 71.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.39% | -10.23% | 15.04% | 37.70% | 71.88% |
| Cost of Revenue | -30.35% | -8.14% | 17.25% | 40.04% | 74.91% |
| Gross Profit | -66.27% | -44.03% | -19.89% | 4.02% | 33.39% |
| SG&A Expenses | 198.80% | 109.99% | 20.56% | 19.37% | 17.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.64% | -5.52% | 17.42% | 39.54% | 73.13% |
| Operating Income | -216.47% | -137.94% | -49.30% | -8.41% | 43.60% |
| Income Before Tax | 139.02% | 56.94% | -37.72% | -0.85% | 45.77% |
| Income Tax Expenses | -38.95% | 36.65% | 188.00% | 144.64% | 101.09% |
| Earnings from Continuing Operations | 200.14% | 62.18% | -76.71% | -29.40% | 33.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 200.14% | 62.18% | -76.71% | -29.40% | 33.18% |
| EBIT | -216.47% | -137.94% | -49.30% | -8.41% | 43.60% |
| EBITDA | -198.27% | -128.05% | -48.86% | -8.07% | 44.10% |
| EPS Basic | 23.36% | -25.32% | -73.15% | -30.94% | 21.09% |
| Normalized Basic EPS | 2.71% | -18.32% | -41.80% | -7.85% | 32.46% |
| EPS Diluted | -4.66% | -38.55% | -72.76% | -29.82% | 23.28% |
| Normalized Diluted EPS | -1.63% | -20.61% | -41.80% | -7.85% | 32.46% |
| Average Basic Shares Outstanding | 90.70% | 60.78% | 29.93% | 20.72% | 10.82% |
| Average Diluted Shares Outstanding | 95.84% | 63.39% | 29.93% | 20.72% | 10.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |